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INTRODUCTION 
The evolution of clinical signs and symptoms produced by meningitis or 
encephalitis varies greatly.  Few conditions in medicine require as rapid and 
accurate therapeutic intervention as acute pyogenic meningitis and viral 
meningitis, yet meningitis can also occur in chronic and recurrent forms.  The 
major problem presented by patients with meningitis is rapid determination of its 
aetiology, the specific basis on which selection of potentially effective 
antimicrobial therapy is predicted.  Thus, the clinician must sort out the form of 
clinical presentation, assess the rapidity of its evolution, and make a specific  
aetiological diagnosis. 
 The examination of cerebrospinal fluid is an essential and often critical tool in 
the evaluation and management of patients with meningitis.  If interpreted 
carefully, the cerebrospinal fluid (CSF) analysis, can be very helpful in guiding the 
diagnostic evaluation and management of patients. 
Although examination of a Gram’s stain of spinal fluid often defines the 
causative agent, this is not always the case.  Cultures have the draw back of the 
time required, 24 to 48 hours or more to become positive, an unacceptable delay in 
initiating the treatment. 
Deivanayagam. N et al (1993)21 Clinical Epidemiology Unit, Madras 
Medical College, have declared that in developing countries, differentiating 
bacterial meningitis from viral meningitis and tuberculous meningitis is not easy. 
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Not all medical centers have viral diagnostic laboratories at their disposal.  
Moreover, serological confirmation of a viral infection is usually of academic 
interest, since by the time its result is available, the patients would have recovered 
or otherwise, it never determines specific therapy. 
Further, the cost of antiviral therapy is very high when compared to 
antimicrobial therapy.  So, in developing countries like India, we can not institute 
empirical antiviral therapy to all patients of suspected viral meningitis.  Therefore, 
several different techniques to discriminate rapidly between viral meningitis and 
bacterial meningitis have been evaluated.  These include Counter Immuno 
Electrophoresis (CIE) of the CSF for the immunoglobulins, lactic acid, creatine 
phosphokinase isoenzyme and C-reactive protein.  Brown et al (1978)15. 
Because of easy availability of the kit and simplicity of the procedure, 
serum C-reactive protein (CRP) was selected to differentiate viral meningitis and 
bacterial meningitis, which is elevated in the latter, were observed in the selection 
of cases. 
 
Further, CRP was used only to differentiate bacterial meningitis from other 
meningitis, but not for the diagnosis of meningitis which was done only by routine 
clinical methods. 
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AIM 
 
 
 
 
To evaluate the efficacy of serum C-Reactive Protein in differentiating 
bacterial meningitis from viral meningitis.   
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REVIEW OF LITERATURE 
 
C-reactive Protein: 
Name Origin: 
During studies of the pneumococcal immune response Tillett & Francis 
(1930)103 found that before the critical fever crisis, the patient’s sera contained a 
component that precipitated a common factor in crude extracts of all 
pneumococci; fraction C. (Gupta and et al. 1987)39. 
 
Chemistry: 
 
CRP is a protein composed of five identical non-covalently bound, globular 
subunits of molecular weight 21,000.  This pentraxin molecule preferentially 
adopts a planar orientation and may stack in  two layers to form decamers.  The 
single peptide chain contains 187 amino acids with only two halfcystine residues 
stabilizing the conformation by forming a disulfide bond (Oliveria et al, 1979)70. 
 
The primary structure shows no repeating sequences and very few 
homologies with other proteins except with serum amyloid plasma P-component.  
CRP migrates as a beta globulin on agarose gel electrophoresis in the absence pf 
Ca2+ and as a slow gamma globulin in the presence of Ca2+ or Ba2+.  Each CRP 
subunit can bind one Ca2+which explains its effect on the electrophoretic mobility.  
Calcium ion includes a conformational change in each subunit and strongly 
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increases affinity of CRP for a series of organic phosphates and for sulphated 
polysaccharides.   Phosphorylcholine has been identified as the binding constituent 
of the pneumococcal C- polysaccharide which caused the phenomenon that gave 
rise to its detection (C-Polysaccharides precipitation and swelling of 
pneumococcal membranes). (Sirijai Chingkul S, et al 2005)93.  The 
Ca2+dependent affinity of CRP for phosphorylcholine, phosphorylated, sulphated 
or Carboxymethylated polysaccharides has been utilized as an efficient 
chromatographic step in the purification of CRP from a wide variety of animal 
species (crabs, fishes, birds and mammals) (Baltz et al, 1981)7. 
 
Physiology: 
 
CRP is an extra cellular protein, synthesized mainly in the hepatocytes.  A 
sub-population of the large lymphocytes, the natural killer cells – are said to have 
endogenous CRP on their surface membranes.  The secretion rate is low in healthy 
subjects and no hepatic store exists.  The Plasma concentration is below 5 mg/L 
and may vary to as low ad 50 µ/L (Kindmark, 1972)56. Though CRP turnover has 
not been measured at the normal steady state, the synthetic rate is estimated to be 
in the order of 1-10mg per day (MacIntrye et al, 1982)63.  CRP is considered to 
constitute a link in one mechanism for eliminating necrotic cells and foreign 
particles in the body (Kushner & Kaplan, 1961)58.  This protective system was 
an earlier evolutionary development than the Ig system.  CRP analogues occur 
normally in the extra cellular fluids of lower animals in concentrations 100 times 
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as high as those in mammals, which only begin to reach similar high values during 
very intense inflammatory reaction. (Vaishnavi c et al 1992)107. 
 
Discussion of the molecular basis of effects of the CRP has been focused 
on its Ca2+ mediated linkage to phosphorylcholine and acid polysaccharides.  The 
disordered architecture of the phospholipid bilayer of cell membranes opens the 
way for calcium ion-mediated linkage of CRP, which then adopts a conformation 
with affinity of C1q of the C1 complex.  This linkage triggers activation of the 
complement cascade along the classical pathway, and reactions characteristics of 
an acute inflammatory response follow.  (Bengershom E. etal 1995)10.  The 
unique binding of CRP to the C-polysaccharide of pneumococcal membranes 
induces in vivo, an enhanced phagocytosis of the microorganisms.  Pneumococci 
are efficiently cleared by the spleen after linkage of CRP  Clinically it has been 
recognized that severe pneumococcal infections are frequent in splenectomised 
patients (Gopal & Bisno, 1977)37. 
 
Pathophysiology: 
 
The CRP linkage to selective polysaccharides of some bacterial membranes 
apparently contributes to induce protective reactions in the host organism even 
when no specific antibodies are present (Volanakis, 1982)109.  The recognized in 
vivo effects of CRP complexes concern activation of the classical pathway of 
complement and activation of phagocytes.  These effects represent an early induc 
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tion of host reactions that are similarly, but probably more efficiently, triggered by 
specific antibodies when they are present.  (Bengershom et al 1995)10 Cell death 
anywhere in the body induces local cellular and vascular reaction and changes in 
the composition of the extra cellular fluids embraced by the concept inflammatory 
response.  This includes an altered protein synthesis in hepatocytes and in the 
phagocytic cells which accumulate around the injured cells.  Messengers carried to 
the liver induce a metabolic shift in the hepatocytes.  This is characterized by a 
decreased synthesis of transport proteins and an increased synthesis of protective 
proteins-particularly Acute Phase (AP) proteins (Kushner, 1982)59.  (Fig.1) AP 
protein inactivate strongly reactive molecules such as proteolytic enzymes and 
oxygen derived free radicals, released or secreted from accumulating phagocytic 
cells or from injured cells.  The continuous exchange of protective proteins, 
between plasma and the intracellular fluids, serve as a buffer system that 
counteracts the rapid intercellular which effect the mobility of the tissue fixed 
macrophages.  Interleukin 1 is a biologically very potent (12,000-15,000 dalton) 
polypeptide which is active in the 10-10 to 10-15 concentration range.  The hepatic 
CRP synthesis is rapidly triggered by interleukin 1 and the plasma concentration 
of CRP starts to rise after about 6 hours.  Experimental data (Mac Intyre et al, 
1982)63 support the idea that a key function of the reticuloendothelial macrophage 
system is to induce accelerated hepatic CRP biosynthesis as much as 100 times 
(1g/d) within the first few days following severe tissue lesion. As the inducer  
disappears CRP synthesis declines to its normal very low rate after a delay, the 
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length of which is primarily determined by the decay of its hepatic m RNA(t ½ 
=4h).  (Ballou et al 1992)9. 
 
The molecular size of CRP suggests an equal distribution between plasma 
and intercellular fluids at a steady state.  The t ½ of CRP in human plasma is of the 
order of 1-2 days, which is shorter than those of all other plasma proteins.  The 
concentration of CRP reflects the local activity of an inflammation better than 
other acute phase proteins because both its faster rise following acute tissue lesion 
and its decline on remission is faster than that of other plasma proteins.  
(Paradowski et al 1998)72. 
Clinical and biochemical advantages 
 CRP is the fastest reacting and most sensitive indicator of an acute 
inflammatory reaction.  It is an useful aid in preliminary differentiation between 
acute bacterial and viral infections with sensitivity and specificity rates of 100% 
and 98% respectively.  (Azeem Shelkh et al 2001)6. 
 
 The increase in plasma concentration of CRP, varying from several fold 
increases with slight tissue lesion to hundred folds with severe lesion, renders the 
CRP concentration a very good semi quantitative indicator of the inflammatory 
process.  Since the survival time of CRP in the circulation is shorter than that of 
other acute phase reactants remission is quickly reflected in a falling CRP 
concentration. (Paradowski et al 1998)72.  The fall in CRP is a sensitive indicator 
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of recovery from infection and provide the earliest check to therapeutic response.  
The slide agglutination tests of anti CRP covered particles is the simple qualitative 
and quantitative test, sufficiently specific and most sensitive.  (Diculencu et al 
1995)24. 
 
 The serum CRP (S-CRP) can be used to differentiate pyogenic meningitis 
or acute meningitis due to other causes.  S-CRP of more than 48 mg/L is sensitive 
and specific for bacterial infection.  A fall in the S-CRP concentration is a 
sensitive indicator of recovery from infection  and provides an earliest clue to the 
therapeutic response, long before a fall in temperature.  (Stearman M, et al 
1994)97. 
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MATERIALS AND METHODS 
 
 Fifty cases with definite clinical signs and symptoms of acute meningitis 
admitted in Govt. Stanley Hospital, Chennai during the period August  2005 to 
September 2006 were taken up for the study.  
 
 All the cases have shown the clinical signs and symptoms of meningeal 
infection.  The following clinical signs and symptoms were given at most 
importance for the selection of cases. 
1. Fever of acute onset 
2. Neck Stiffness  : Passive flexion of the neck is difficult or  
Impossible  
  
 
3. Kernig’s sign  :  With the patient on supine posture, when     
the hip is fully flexed the passive 
extension of the patient’s knee, causes 
pain and spasm of the hamstrings in 
meningeal irritation affecting the lower 
part of the spinal subarachnoid space. 
 
4. Brudzinski’s Sign  : (i) Contralateral reflex or Sign: 
      On passive flexion of the leg on one side,  
a similar movement occurs in the  
opposite leg. 
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(ii) Neck Sign :  When the neck is 
passively flexed, flexion of the hip and 
knee occur. 
 
5. Symptoms of increased intracranial pressure like Headache, Vomiting. 
 
6. Altered Sensorium :    
  
 All the selected cases were investigated for serum C-reactive protein levels 
which was done by Rapid latex test.  CSF study was done in all cases, to confirm 
the S-CRP findings.  In one case lumbar puncture was not done because of 
bilateral papilledema. 
CSF Analysis : 
 The cerebrospinal fluid was tested for  
a. Colour  : Clear, turbid, Opalescent, High coloured and/or  
blood stained. 
b. Tension  : Normal or elevated 
c. Cell count  : Cerebrospinal fluid was stained for cell count  
and examined under High power field for rapid 
results. 
d. Staining  : A drop of centrifuged CSF was placed over the  
glass slide, dried and stained for AFB and 
Gram’s stain. 
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e. Cob web  : 2ml of CSF was collected in a test tube and  
mounted in a rack.  Examined after 24 hours for 
the presence of cobweb.  If present, the 
precipitate was again centrifuged and stained 
for AFB. 
 
f. Culture  : CSF was sent for culture and sensitivity. 
 
g. Biochemical Analysis : CSF was sent for estimation of globulin,  
proteins, sugar and chloride.  
 
The results were correlated with the results of S-CRP levels and the cases 
were differentiated into bacterial meningitis or meningitis due to other causes.  
 
Inclusion Criteria 
1.  Above 12 years of age 
2.  History suggestive of meningitis 
3.  Neck Rigidity 
Criteria Observed for serum CRP testing 
 All cases which had the following history were excluded from the study in 
order to avoid false positive S-CRP results. 
1.  Recent injury of any kind. 
2.  Recent surgery. 
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3.  Patients in the immediate post-partum period, 
4.  Known case of Rheumatic Heart Disease (according to modified Jones  
     Criteria) 
5.  Known case of Rheumatoid arthritis (according to ARA diagnostic  
     Criteria) 
6.  Known case of acute or chronic glomerular nephritis and all cases of 
      Genito- Urinary  tract infection. 
7.  Focal infections like pneumonic consolidation, infections of skin etc.,  
 
PRINCIPLE 
 
 Principle is based on a rapid agglutination procedure for the direct detection 
and semi-quantitation (on slide) of C-reactive protein (CRP).  The reagent, a latex 
particle suspension coated with specific anti-human C-reactive protein antibodies, 
agglutinates in the presence of CRP in patient serum.  
REAGENTS 
 
a. CRP LATEX:     1 x 1.5 ml / 1 x 2.5 ml 
Suspension of polystyrene particles coated with anti-human CRP 
goat antibodies. 
 
b. CRP POSITIVE CONTROL    1 x 0.5 ml 
 Human pooled serum 
 
c. CRP NEGATIVE CONTROL    1 x 0.5 ml 
 Human pooled serum 
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d. GLYCINE SALINE BUFFER CONCENTRATE 1 x 5 ml 
 Dilute 1.10 with distilled water. 
 
e. Accessories          For 30 T         For 50 T 
  Reaction slide     1     1 
  Plastic Droppers   30   50 
  Applicators sticks   30   50 
  Rubber Teat (Blue)     1     1 
 
PRECAUTION 
 
 The reagents of human origin, used in the study have been tested and found 
to be negative for the presence of antibody to HIV I and II  as well as for HBs Ag 
and HCV antibody. 
 The reagent and controls contain less than 0.1 % of sodium azide. 
 
STORAGE AND STABILITY 
 
 1. Stored at 2-80C 
 2. Protected from light 
 3. Stability as per kit used. 
PREPARATION  OF GLYCINE SALINE BUFFER 
 
 Glycine saline buffer was prepared by adding 45ml of distilled water to 
0.5ml of concentrate glycine saline buffer. 
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SENSITIVITY 
 
 The CRP sensitivity has been adjusted to detect a minimum of 0.6 mg/dL in 
the undiluted sample. 
SAMPLE 
 
Fresh serum sample (free of haemolysis). 
 
QUALITATIVE TEST 
 
All reagents, as well as the sample were allowed to reach room 
temperature, and mixed well, before use. 
1. One drop of serum sample was placed on to the slide with the help 
of disposable serum dropper. 
2. One drop of CRP-Latex antigen was added to the above drop and 
mixed well with disposable applicator stick. 
3. Slide was gently rocked to and fro for 2 minutes and examined under 
a good light source for agglutination within 2 minutes. 
4. For positive & negative controls, the same procedure as mentioned 
above, was followed, by taking control serum from respective vials.  
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RESULT AND INTERPRETATION 
POSITIVE RESULTS 
 The presence of agglutination indicates concentration of CRP in the sample 
equal to or greater than 0.6 mg/dL. 
 
NEGATIVE RESULTS 
 
The lack of agglutination indicates a CRP concentration lower than               
0.6 mg/dL. in the sample. 
 
SEMI–QUANTITATIVE TEST–BY SERIAL DILUTION METHODOLOGY 
 
1. 50µL dilute Glycine saline Buffer was placed on to each of five circles of 
the slide. 
2. Using a 50µL (0.05 mL) micropipette, 50µl (0.05ml) of the serum sample 
was added to the drop of Glycine – Saline Buffer in 1st circle.  
3. Using the sample micro – pipette, the sample was mixed with saline by 
aspirating back and forth several times.  50µl (0.05ml) from 1st circle was 
aspirated and transferred to 2nd circle.  The same operation was repeated 
upto the 5th circle. 0.05ml from 5th circle was aspired and discarded. 
Following dilutions were obtained 
Dilution : 1/2     1/4     1/8      1/16         1/32 
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4. One drop of CRP-latex Antigen was added, to each of the above circles and 
the slide was rocked gently to and fro for 2 minutes.  Agglutination was 
observed under a good light source. 
 
CALCULATIONS 
 
 Whenever S-CRP is negative or positive in 1:2 or 1:4 serum it is taken as 
<5mg/L  and 6mg /L respectively.  If positive, in 1:8 dilution, it is 12-18 mg/L and 
in 1:6 dilution as 24 – 48 mg/L.  The reading is taken as >48 mg/l whenever it is 
positive in 1:32 dilution. 
 
Sl.NO. Dilution Qualitative Quantitative 
1.  1/2 (-) < 5mg/l. 
2.  1/4 (+) 6-12 mg/l 
3.  1/8 (++) 12-24 mg/l 
4.  1/16 (+++) 24-48 mg/l 
5.  1/32 (++++) >48 mg/l 
 
The value of S-CRP in differentiating bacterial from non-bacterial meningitis 
was cross checked with CSF studies (Sugar, Protein, AFB, gram stain) and serum 
& CSF cultures. 
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CSF analysis observed for bacterial meningitis was 
 
 CSF Proteins  >  45 mg /dl 
 CSF Sugars  <  40 mg /dl 
 CSF Cell count   Raised with predominant  
                                                                   polymorphonuclear (PMN) 
      cells  
 (Harrison 16th  edn) 
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OBSERVATION AND RESULTS 
 
 In the study of fifty cases of acute meningitis admitted in Govt. Stanley 
Hospital, Chennai, the following observations were made in sex incidence, age,  
clinical presentations,  CSF analysis, serum C-reactive protein level and  prognosis 
of the illness as follows: 
 
Sex Incidence: 
 
 Fifty cases of acute meningitis infection have been observed.  The study 
showed a male predominance of 56% while the female was 44%. (Table –I) 
Table – I 
SEX INCIDENCE IN THE STUDY 
 
 
 
 
 
 
 
 
 
 
Age Incidence: 
 
 
 It is observed in the study that, 16 cases belong to the age group of 13-20 
years (32%), another 14 cases (28%) in 21-40 years group, 16 cases (32%) were 
from 41-60 years group and 4 cases (8%) were above 60 years of age. (Table – II) 
 
Sl. No Sex 
Number of 
patients 
Percentage %
1. Male 28 56% 
2. Female 22 44% 
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TABLE – II 
AGE INCIDENCE IN THE STUDY 
 
 
Sl. No Age in Years 
Number of 
patients 
 
Percentage %
1. 13-20 16 32% 
2. 21-40 14 28% 
3. 41-60 16 32% 
4. >60 4 8% 
 
Symptoms: 
 
The sequence of symptoms observed from the study were as follows. 98% 
(49) of cases presented with fever while 48% (24) presented with vomiting.  
(Table- III). 
TABLE – III 
SYMPTOMS TABLE 
Sl. No Symptoms & Sign 
Number of 
patients 
Percentage 
% 
1. Fever 49 98% 
2. Altered Sensorium 41 82% 
3. Head ache 30 60% 
4. Vomiting 24 48% 
5. Neck rigidity 50 100% 
6. Seizures 21 42% 
7. Neurological deficits 20 40% 
8. Abdominal pain & Diarrhoea 5 10% 
 
 The incidence of  seizure were observed in 42% (21) of cases, 40% (20) 
had neurological deficits and 10% (5) had abdominal pain and diarrhoea. 
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Meningeal Signs: 
 
 Neck stiffness was seen in all the fifty cases, as it was considered as               
the prime sign for the selection of cases.  Thirty eight cases (76%) were found to 
have positive Kernig’s sign whereas Brudzinski’s sign was positive in thirty         
cases (60%). 
 
 
Papilledema 
 
 Papilledema was present in seven out of fifty cases.  Among them five 
belong to bacterial meningitis group, of which three expired.  The other two who 
belong to non bacterial group have recovered and are alive. 
 
TABLE – IV 
FUNDUS EXAMINATION 
Sl. No Fundus 
Number of 
patients 
 
Percentage %
1. Normal 43 86% 
2. Papilledema 7 14% 
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Neurological Deficit: 
 
Abducent Nerve Palsy: 
 
Of the fifty cases, five cases developed VI cranial nerve palsy.  Among the 
five, the VI Cranial nerve palsy was unilateral in four and bilateral in one who has 
papilledema also.  
 
Three cases belonged to the bacterial meningitis group, of which two were 
having papilledema.  One case belonged to the viral meningitis group, and one 
belonged to tuberculous  meningitis group.  Of the five, two expired  (Table – V). 
TABLE – V 
NEUROLOGICAL DEFICITS  
Sl. No Neurological Deficits 
Number of 
patients 
 
Percentage %
1. Abducent nerve palsy 
5 
(3B, 1V, 1TB) 
10 % 
2. Facial Nerve palsy 
4 
(1B, 3V) 
8 % 
3. Other Cranial Nerve palsy 0 0 
4. Aphasia 
4 
(1B, 2V, 1TB) 
8 % 
5. Hemiparesis 
6 
(1B, 5V) 
12 % 
6. Quadriparesis 
1 
(V) 
2 % 
 
B – Bacterial, V-Viral, TB – Tubercular. 
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Facial Nerve Palsy 
 
 Four cases were found to have unilateral VII cranial nerve palsy of which 
three belonged to the viral meningitis group, two of them presented with 
papilledema, hemiparesis and aphasia.  All of them survived.  (Table – V). 
 
Hemiparesis 
 Hemiparesis was observed in six cases.  (Table - V).  One belonged to the 
bacterial meningitis group, who had papilledema and VI cranial palsy expired.  
Five cases belonged to the viral meningitis group.  Two had associated 
papilledema, VII cranial nerve palsy and aphasia. 
Aphasia 
 
 Four cases developed aphasia during the course of illness.  Two had 
associated papilledema, VII cranial nerve palsy and hemiparesis.  Of these, one 
was bacterial, one tubercular and two of viral origin.  (Table V). 
Quadriparesis  
 
 One case belonged to the viral meningitis group, developed spasticity in all 
the four limbs, (Table – V) soon became unconscious and expired.  No other 
neurological abnormalities were observed. 
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S-CRP and mortality 
 
 S-CRP levels were analyzed in all the fifty cases.  Sixteen cases (32%) 
showed negative results for S-CRP indicating a possibility of viral infection.  Of 
these nine cases (18%) expired.  Nine cases (18%) were having S-CRP of 6 mg/L 
level, of which 2 cases (4%) expired.  Eight cases (16%) had S-CRP levels 12-18 
mg/L level of which there was no mortality.  Nine cases (18%) had S-CRP levels 
24-48 mg/L, of which one died (2%) and eight cases (16%) were having strongly 
positive levels of > 48 mgms / L indicating a definite bacterial infection, of which 
two cases (4%) expired. (Table – V). 
TABLE – VI 
SERUM – CRP AND MORTALITY 
Sl. 
No 
S-CRP 
(mg/l) 
S-CRP 
Qualitative 
Number of 
patients 
 
Death Percentage % 
1. <6 - 16 9 18% 
2. 6 – 12 + 9 2 4% 
3. 12 – 24 ++ 8 0 0% 
4. 24 – 48 +++ 9 1 2% 
5. >48 ++++ 8 2 4% 
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 In 25 cases, S-CRP levels were less that 12 mg/l. of these, 16 cases had 
SCRP <6 mg/l and 9 cases had SCRP 6-12 mg/l.  All these 25 cases were having 
clinical signs in favour of meningitis or meningoencephalitis and CSF formula in 
favour of viral infection.  The CSF glucose level in all the 25 cases were near 
normal limit and protein is normal or slightly elevated, indicating the possibility of 
viral infection.  
 
S-CRP and prognosis 
 
 In all fifty cases, S-CRP was done first, at admission, second after three 
days of hospitalization and the third one before discharge, so as to assess the 
prognosis of the patient.  
 
 Of these, sixteen had shown a rapid fall in S-CRP levels and a very good 
prognosis.  The S-CRP indicated  good prognosis earlier than other investigations.  
One case was having sustained high S-CRP levels and expired despite treatment.  
 
 In another eight cases who were positive for S-CRP levels subsequent tests 
revealed negativity and this again indicated a good prognosis. 
 
 In the remaining twenty five cases, the S-CRP levels were negative, 
subsequently tested again to rule out false negativity but it revealed the same 
results.  
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Level of Consciousness and Mortality 
 It is observed from the study that 4 cases were unconscious at the time of 
admission.  Of them, two between 21-40 years, had history of unconsciousness for 
6 hrs.  One of them had a S-CRP level of >48 mg/L and the CSF picture in favour 
of bacterial infection, showed a very good improvement from treatment with 
antibiotics. 
TABLE – VII 
LEVEL OF CONSCIOUSNESS AT ADMISSION 
Sl. No Level of  conscious Number of patients Percentage % 
1. Conscious 9 18% 
2. Semiconscious 37 74% 
3. Unconscious 4 8% 
4. 
Semiconscious later 
became unconscious 
12 24% 
 
 
The other one, of the 13-20 age group and a S-CRP level of <6mg /L and a 
CSF picture in favour of viral infection, was treated with antibiotics and other 
supportive measures showed a good prognosis. 
The remaining two cases between 21-40 years who were admitted in 
unconscious state, developed unconsciousness 48 hrs before admission which 
showed a delay in admission. One of them had a S-CRP level of <6mg/L and CSF 
picture in favour of viral infection and not improved with adequate supportive 
measures, had only two days of hospitalization and expired. (Table – VII). 
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The other one was having Cheyne-Stoke breathing with papilledema and 
other clinical signs in favour of CNS infection.  The C.T. scan was normal, but the 
serum C-reactive protein was found to be very high > 48 mg/L. 
 
Thirty seven cases were found to be semiconscious on admission.  The 
symptom duration before admission varied from few hours to three weeks.  
Twenty five cases were showing improvement with antibiotic treatment.  
 
Twelve cases became unconscious soon after the admission and expired 
despite all possible supportive measures.  Of the twelve cases, eight cases were of 
adolescent (13-20 years) age group, three cases were between 20-40 years and one 
between 40-60 years. 
 TABLE – VIII 
LEVEL OF CONSCIOUSNESS AND MORTALITY 
Sl. 
No Level of conscious 
Number of 
patients Death 
Percentage 
% 
1. Conscious 9 0 0 
Semiconscious    
a. Disoriented 13 2 4 
b. Not obeying commands 13 3 6 
2. 
c. Became unconscious not 
responding  to painful Stimuli. 
 
11 9 18 
3. Unconscious 4 2 4 
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Among the three adults, one was a known case of pulmonary tuberculosis 
(by sputum examination).  His CSF picture was in favour of a definite tuberculous 
meningitis positive for cobweb AFB stain and S-CRP levels of 24-48 mgs/L.  He 
was not showing any improvement with adequate antibiotics, antituberculous 
drugs and steroid therapy. Patient developed hydrocephalus, confirmed by C.T.  
scan and expired.  The other two adult cases were having a CSF picture in favour 
of viral infection and this is supported by low S-CRP levels of <6 mg/L.   They did 
not improve with antibiotic treatment and expired. (Table – VIII). 
 
Cerebrospinal Fluid 
 
 Lumbar puncture was done in all fifty cases.  In seven cases, guarded 
lumbar puncture was done due to papilledema and bad clinical condition.  In two 
cases the AFB staining was positive. (4%). 
 
 Ten cases had Gram positivity and seven had Gram negativity.  All the 
seventeen were observed to have low CSF sugar value and with empirical 
treatment all the patients had good prognosis.  Also all the 8 persons with S-CRP 
of 12-24 mg/l were Gram negative. 
 
 Seven cases were observed to have positive cob-web of which two were 
AFB positive.  All the seven cases were found to have elevated proteins, normal or 
low sugar values in the CSF.  The CSF culture was positive in twenty five of the 
fifty cases. 
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CSF Cell Count 
 
 There was significant pleocytosis in thirty six cases (of which seventeen  
cases were having elevation of polymorphonuclear cells which are usually absent 
in normal CSF, and nineteen cases had lymphocyte predominance.  Ten cases 
were found to give positive results for Gram’s staining as already stated.  Eight 
cases were having S-CRP levels of more than 48 mg/L, 9 cases were having             
S-CRP level between 24 to 48 mg/L, 12 to 18 mg/L in 8 cases,6mg/l in one case 
and <5mg/L in four cases. One of the four cases with CRP levels <5mg/l, three 
cases had a poor prognosis and expired.  All the seventeen cases showed a marked 
fall in CSF sugar levels and elevated protein levels. 
 
 The other cases with S-CRP between – to ++, were having elevated         
CSF lymphocytes.  In these groups, two cases were positive for AFB staining and 
seven for cob web suggestive of tuberculous meningitis.    Five cases had levels of 
24-48mg/L of which, one case had a bad prognosis, developed hydrocephalus and 
expired.  In five cases the S-CRP levels were between 12 to 18 mg/L and  6 to 
12mg/L in six cases of which one case expired who had elevated protein and 
normal sugar in CSF.  Seven cases had S-CRP levels of <5mg/L of which three 
cases expired, all of them showed a near normal protein and sugar levels in CSF. 
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Positive Predictive Value Estimation 
 Twenty five cases had S-CRP of >12 mg/l.  Of these, seventeen cases were 
diagnosed  to have bacterial meningitis and eight cases of tuberculous meningitis. 
PPV = TP / (TP + FP) 
= 17 / (17 + 8) 
= 17 / 25 
= 68% 
PPV  - Positive predictive value TP – True positive  FP – False Positive 
 
Sex and Mortality 
 The total mortality rate of the study was 28%  (14 cases).  Of which 18%  
(9 cases) were males and 10% (5 cases) were females. (Table – IX). 
 
TABLE – IX 
SEX AND MORTALITY  
Sl. 
No Prognosis Sex Number  
Percentage 
% 
M 19 38% 
1. Survived 
F 17 34% 
M 9 18% 2. 
Dead 
F 5 10% 
 
 Of the 72% cases who survived, 38% (19 cases) were males and 34%              
(17 cases) were females.  It shows a male predominance in mortality rate also.  
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TABLE – X 
AGE GROUP AND MORTALITY  
Sl. 
No Age in years 
Number of 
Patients Death 
Percentage 
% 
1. 13 – 20 16 8 16% 
2. 21 – 40 14 2 4% 
3. 41 – 60 16 2 4% 
4. > 60 4 2 4% 
 
As shown in the Table – X, 8 cases of 13-20 years of age group expired, 
constituting a  mortality rate of 16% and 4% each in all other age groups. 
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DISCUSSION 
 
 Meningeal infection still remains a significant health problem, although the 
overall incidence had decreased.  The diagnosis and treatment of actue meningitis 
is a challenge for the primary care physician.  The earlier the recognition of 
bacterial meningitis and the more rapid the institution of antimicrobial therapy,  
the better the chance of a favourable outcome.  Since the modality of treatment for 
bacterial and viral meningitis are totally different, it is very important to 
differentiate the meningitis on aetiological basis from bacterial and viral origin. 
 It is generally held that the confirmation of viral meningitis by means of a 
positive culture is of academic interest, since no specific antiviral therapy  exists to 
change the clinical outcome.  The CSF examination is most critical in 
distinguishing bacterial from viral meningitis.  When a definite diagnosis of viral 
meningitis is made, anti-microbial therapy could be discontinued and the hospital 
stay might be significantly shortened. 
 
 Not all medical centers have viral diagnostic laboratories at their disposal.  
Moreover, the serologic confirmation of a viral infection is usually of academic 
interest, since by the time its result is available, the patient has recovered  and it 
never determines specific therapy.  Therefore, several different techniques to 
discriminate rapidly between viral and bacterial meningitis have been evaluated.  
These include counter immunoelectrophoresis (CIE) of the cerebrospinal fluid 
 42
(CSF) for the detection of viral antigens and examination of the CSF for 
immunoglobulins, Lactic acid dehydrogenase, creatine phosphokinase isoenzyme 
and C-reactive protein (CRP ).   
 
 The sine quo non of establishing viral meningitis on the basis of culture is 
very expensive and moreover it is not available in most of the places in our 
country and unfortunately no simple and easily performed procedure to distinguish 
viral from bacterial meningitis is available which has 100 percent predictive 
positive and negative values.  For this reason the C reactive protein (CRP) was 
chosen to differentiate bacterial from viral infections of the central nervous 
system. 
 
 Abramson J.S. Hamton K.D. et al 19851 studied the use of C-reactive 
protein for differentiating meningitis and have pointed out that the C-reactive 
protein may be the single best non specific indicator of bacterial infection with 
sensitivity and specificity rates of 100 and 98 percent, respectively. 
 
 Further the serum C-reactive protein measured by rapid latex test can be 
done as a bedside procedure which cost only thirty rupees and two minutes time.  
If the result is viral, unnecessary antibiotics administration for prolonged period 
can be avoided, and only supportive measures are sufficient for all cases of viral 
meningitis.  Even if the virus is isolated, at present no specific antiviral drug 
therapy is available. 
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 Therefore, the serum C-reactive protein estimation is most useful in 
differentiating bacterial from viral infection of the central nervous system, 
especially for developing countries like ours, even in peripheral medical centers. 
Sex Incidence 
 
 Meningeal infection both bacterial and viral has got a male predominance 
as observed in the study correlations well with the study of National Institute of 
Communicable Diseases68, Directorate General of Health, India, during the 
epidemics of bacterial meningitis in the year 1966, 1985 and 1987.  The male 
predominance of 69 percent was shown Etter C.G. 199126 in his study on viral 
meningitis. 
 
Age Incidence 
 
 32% were in 13-20 years age group whereas 28% were in 21-40 years age 
group and 32% were in 41-60 age group, which correlates well with Choi, C 
199217 who has pointed out that meningitis remains a significant health problem 
for the older adults.  Although the overall incidence of the disease has decreased, 
the incidence of meningitis in older adults is increasing and the recognition of 
meningitis in the older adults may be more difficult. 
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Symptoms 
 It is observed in the study that, fever is the most common presenting feature 
(98%) of meningeal infection compared to the 85% as per the study of Rosa. K.L. 
et al (1991)85 and Feigin R.D. et al (1992)28.  According to Dufour J.F. (1991)23 
it is 80% whereas Rasmussen, H., Nielsen, B. 199281 stated an incidence of 79%. 
 Seizures were found in 42% of cases in the study whereas it is 30.4% in the 
study of Pomeroy et al (1990)76 and 30% by Feigin R.D. et al in 198127. 
 
Signs 
 Altered sensorium was found in 82 percent of cases in the study as 
compared to 69% in the study of Rasmussen H., Nielson. B., et al 199281.  
Further the altered sensorium was more commonly associated with viral 
meningoencephalities.  Tyler. K.L. in 1984106 and Whitely R.J in 1990113 noticed 
an increased incidence of altered sensorium in viral encephalitis when compared 
to bacterial meningitis. 
 
Meningeal Signs 
 
 Neck stiffness was present in all cases as it was considered as the prime 
sign for the selection of cases.  The Kernig’s sign was present in 76% cases and 
the Brudzinski’s sign in 60% of cases whereas Feigin.R. D., et al in 198127 and 
199228 have noticed only 50 percent of cases were having these meningeal signs.  
This was also supported by Spanson et al in 198996 and Rasmussen. H., Nielsen, 
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B et al in 199281.  In another study, by Dufour JF in 199123 the incidence of 
meningeal signs was over 80%. 
 
Neurological Deficits 
 It is observed in the study that, hemiplegia with facial nerve involvement, 
was the commonest neurological deficit with an incidence of 12 percent isolated 
abducent nerve palsy unilateral or bilateral having an incidence of 10% tops the 
cranial nerve deficits whereas isolated facial nerve palsy and isolated aphasia were 
found in 8% of cases each and Quadriparesis in one case.  The overall 
neurological deficits in the study was 40 percent, in contrast to the study of 
Swartz MN et al 196598 and Pomeroy LS et in 199076,  who have noticed an 
incidence of only 10% and 20% of neurological deficit in viral and bacterial 
meningitis respectively. 
 
Serum C-Reactive Protein 
 
 The ability of serum C-reactive protein (S-SRP) to differentiate between 
acute bacterial and non-bacterial meningitis was evaluated in fifty cases, of adult   
population.  The patients underwent lumbar puncture for suspected central nervous 
system (CNS) infections. 
 
 Of the fifty cases, 17 cases were diagnosed as bacterial meningitis, another 
33 cases as meningitis due to non-bacterial causes.  In patients with bacterial 
meningitis eight cases were having the S-CRP levels of more than 48 mg/L.  The 
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S-CRP levels of 24-48 mg/l, were found in 9 cases.  In eight cases, S-CRP was  
12-24 mg/l. and  were diagnosed as tubercular meningitis.  There was no case 
of fungal or atypical meningitis in the study. 
 
 In nine cases the S-CRP levels were 6-12 mg/L.  In sixteen cases the           
S-CRP was <5 mg/L.  All the 25 cases were diagnosed as cases of viral 
meningitis. 
 
 Therefore, a significant positive S-CRP supported by. 
 1. Cerebrospinal fluid pleocytosis. 
 2. Elevated protein and low CSF sugar 
3. A CSF sugar value of less that 35 mg/dl. was taken as evidence of 
bacterial aetiology. 
 
 From the study, in adults, a S-CRP level of less than 6 mg/l. with clinical 
signs of meningitis, is a definite indicator of viral meningitis.  Whereas, a S-CRP 
level of more than 48 mg/l indicates a definite bacterial aetiology; this is supported 
by Hensen. L., Kamin, W 199246 and Riberio, M.A. Kimura, R.T., 199283. 
 
 As the patients who have shown a S-CRP level of 24-48 mg/l and 12-24 
mg/L were having the history of preadmission treatment with antibiotics and 
steroids.  These patients may have partially responded to the treatment, further the 
steroids might have reduced the S-CRP level.  This view if supported by Smith et 
al (1990)94, and H. Gevold, H.E. et al in 199232 as per their studies, the steroids 
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inhibit macrophage secretion and synthesis of interleukin 1 the messenger and 
modulator for CRP stimulation from hepatocytes.  In all these patients, the CSF 
analysis showed a definite possibility of bacterial meningitis.  Therefore in 
patients, who give history of pre-admission treatment with steroids a S-CRP level 
of more than 48 mg/l may also indicate bacterial aetiology. 
 
S-CRP and Prognosis 
 On serial monitoring, it is observed that a fall in the S-CRP concentration is 
a sensitive indicator of recovery from meningeal infections long before other 
signs. 
 
 Of the eight cases who had S-CRP level of more than 48 mg/L., 6 patients 
had a good prognosis which has been demonstrated by repeated S-CRP and by 
repeated lumbar puncture. 2 cases expired within 2 days of hospitalization despite 
adequate antibiotic therapy, they were unconscious at admission and had poor 
general condition. 
 
 To assess the prognostic value of S-CRP, the test was done first at 
admission, the second, 3 days after hospitalization and the third one before 
discharge.  Six cases showed a rapid fall of more than 10 mg/L in S-CRP levels 
had a very good prognosis.  
 
 In one case the S-CRP levels showed a sustained high level.  The repeated 
CSF examination showed near normal values in favour of a good prognosis.  But 
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the patient developed hydrocephalus and expired despite all possible supportive 
measures.  This shows that S-CRP is a better prognostic indicator than repeated 
CSF examination, thereby reducing the repeated invasive techniques.  This is 
consistent with the study of Kobli V, and Singh. S. (1993)57. 
 
 Macfarlane62 reported 97% sensitivity and 98% specificity to differentiate 
bacterial from viral meningitis by means of CRP testing.  Whereas Benjamin11 
observed the test to be less sensitive i.e. 66% while Gutterberg40 found it to be 
useless, Gupta D. 198739 observed a sensitivity of 60% and specificity of 92% in 
distinguishing bacterial and viral meningitis.  The S-CRP level of more than 48 
mg./L was taken as the cut off point for pyogenic meningitis.  In distinguishing 
partially treated pyogenic meningitis from tuberculous meningitis, CRP had a 
positive predictive value of 90%. 
 
Mortality 
 
 It is observed from the study that, the overall case fatality rate was 28%  
(14 cases).  All these cases were found to have altered sensorium at the time of 
admission.  This indicates an increase in case fatality rate in patients who had a 
altered level of consciousness at the time of admission and is supported by the 
study of Deivanayagam N et. al, clinical epidemiology unit, Madras Medical 
College in 199321, who pointed out a case fatality rate of 22% particularly in cases 
who had an altered level of consciousness on admission. 
 49
 In the study, the survival rate was 72% where as the study of Rasmussen 
H, Nielsen B., et al in 199280 stated a survival rate of only 63% and fatality rate of 
37% probably due to late arrival to hospital. 
 
 The mortality rate also shows a male predominance of 18 percent whereas 
the incidence in females is 10 percent.  Bacterial meningitis consists of 6% 
mortality whereas viral meningitis has a mortality rate of 22%. 
 
Others 
 It is observed in the study that the cerebrospinal fluid culture was positive 
in 50% and the Gram’s stain was informative in 34% of cases whereas, AFB 
staining was informative in only 4% cases.   This is in contrast to 65% positivity 
of culture and 54% in Gram’s stain as reported by Bohr. V. et al in 198312. 
 
Further, the culture positivity fall from 65% to 38% and the Gram’s stain 
positivity from 54% to 34% among patients with prior antibiotic use, supported by 
Bohr. V. et al12, Rasmussen N, Hensen, B et al 198381. 
 
 As the antibiotics are freely used in all patients with fever irrespective of 
the age group, a positive culture or cerebrospinal fluid biochemistry may be 
difficult to achieve as per the study of Jiao F.Y., Ceo. H.C., et al 199253. 
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CONCLUSION 
 
1. Estimation of C-reactive protein in serum is the cheapest, sensitive and 
 specific test to differentiate bacterial from viral infections. 
 
2. It is a simple qualitative as well as quantitative test and can be done as a   
           bed side investigation.     
 
3. With serum C-reactive protein, a definite aetiological diagnosis can be 
 made rapidly at the time of admission itself. 
 
4. A serum CRP level of less that 6 mg/l with clinical signs of meningeal 
infection is a definite indicator of viral meningitis. 
 
5. A serum CRP level of more than 48 mg/l with clinical signs of meningeal 
 infection is a definite indication of bacterial meningitis. 
 
6. Preadmission treatment with steroids cause a fall in CRP levels in 
 bacterial meningitis. 
 
7. Serum CRP has 68% predictive value in adults. 
 
8. The rapid differentiation facilitates an early, accurate and appropriate 
 therapy thereby reducing the morality and morbidity rates, the overall cost 
 of the treatment and the duration of hospitalization. 
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9. Serum CRP can be used as the best and most sensitive bedside prognostic 
 indicator of bacterial infections. 
 
10. Meningeal infections have a definite male predominance. 
 
11. Altered level of consciousness at the time of admission is associated with 
 bad prognosis and high case fatality rate (28%) 
 
12. Fever is the commonest presenting feature followed by altered sensorium, 
 symptoms of increased intracranial tension and seizure.  Among 
 neurological deficits, hemiparesis, VIth cranial nerve palsy and VIIth 
 cranial nerve palsy were found to be common. 
 
13. The earlier the recognition of bacterial meningitis and more rapid the 
 institution of antimicrobial therapy the better the chance of a favourable 
 outcome. 
 
14. Therefore, the serum C-reactive protein estimation is most useful in 
 differentiating bacterial meningitis from viral meningitis, especially for  
           developing countries like India, even in peripheral health centres. 
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PROFORMA 
 
1. Sl. No.  : 
 
2. Name  : 
 
3. Age  : 
 
4. Sex  : 
 
5. QUESTIONNAIRE OF THE SYMPTOMS: 
 
i) Whether the patient had Fever?  1. Yes  2. No. 
 
ii) Whether the patient had vomiting? 1. Yes  2. No. 
 
iii) Whether the patient had headache?  1.Yes   2.No 
 
iv) Whether the patient had Seizures?   1. Yes 2. No. 
 
v) Whether the patient has any weakness?  1. Yes 2. No. 
 
6.  CLINICAL EXAMINATION: 
 A  -   PULSE 
 B  -   BLOOD PRESSURE  
 C  -   RESPIRATORY RATE 
 D  -   TEMPERATURE 
 E  -   GENERAL EXAMINATION 
 F  -   SYSTEMIC EXAMINATION  
  I. CENTRAL NERVOUS SYSTEM 
   1. Neck Regidity 
   2. Kernig’s sign 
   3. Brudzinski’s sign 
   4. Cranial Nerve involvement 
  5. Papilledema 
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  II. CARDIOVASCULAR SYSTEM 
  III. RESPIRATORY SYSTEM 
  IV. ABDOMEN 
 
7.  INVESTIGATIONS: 
  BLOOD: 
  - Haemoglobin 
 - Total Count 
 - Differential Count 
 - Erythrocyte sedimentation rate 
 
8. X-RAY CHEST PA - VIEW 
 
9. SPECIAL INVESTIGATIONS: 
A – SERUM C – REACTIVE PROTEIN (S-CRP) 
B -CEREBRO SPINAL FLUID 
 - Cell Count 
 - Glucose 
 - Protein 
 - Culture 
 - AFB 
 - Gram’s stain 
10.   PROGNOSI 
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1 HUSSAIN BASHA 20 M + + + + - - + + + + - - L 39 46 D - - - 
 
2 JOSEPH 18 M + + + - + - + + + + + 3+ PMN 26 55 D + - +
 
3 KUMAR 19 M + - + + - - + - - - - - L 40 44 D - - - 
 
4 JAYARAMAN 18 M + + + - - + + + - + + 3+ PMN 23 60 D + - +
 
5 VIMAL 16 M + + + + + - + - - + - 2+ L 28 50 A + + - 
 
6 VIGNESH 15 M + + - - - - + - - - - 4+ L 29 62 A + - - 
 
7 KUPPUSAMY 20 M + + + + + - + - - + - 2+ L 30 49 D - - - 
 
8 SRINATH 14 M + + + + - - - - - - - 4+ PMN 22 61 A + - +
 
9 KRISHNAVENI 19 F + + + + + - + + + + + 3+ PMN 23 59 D + - - 
 
10 KALPANA 18 F + + + + - - + + + - - 1+ L 27 52 A - - - 
 
11 SHYAMALA 15 F + + + - - - + + + - - 2+ L 28 56 A + - - 
 
12 GAYATHRI 17 F + + - - - - + + - - - 3+ PMN 19 60 A + - +
 
13 KAVITHA 18 F + + + + - + + - - - - - L 40 43 D - - - 
 
14 ANITHA 17 F + + + + - - + + + - - 3+ PMN 21 51 A + - +
 
15 FATHIMA 17 F + + + + - - + + - - - 2+ L 30 48 A + - - 
 
16 FARITHA BEGAM 18 F + + + + - - + - - - - - L 39 42 D - - - 
 
17 RAVI 35 M + + + + - - + - - - - + L 38 44 A - - - 
 
18 BASKAR 23 M + + - - - - + - - - - 4+ PMN 18 63 A + - +
 
19 CHAKARABANI 36 M + + + + - - + + + + - - L 37 43 D - - - 
 
20 KANNAIYAN 34 M + + - - - - + - - - - - L 37 40 A - - - 
 
21 MUTHU 28 M + + + + - - + + + - - 2+ L 26 49 A + - - 
 
22 BALA 22 M + + + + + - + + + + - 4+ PMN 18 62 A + - +
 
23 VAIRAVEL 36 M + + + + - - - + + - - 1+ L 33 47 A - - - 
 
24 VELAYUTHAM 25 M + + + + - + + + + + - - L 38 43 D - - - 
 
25 VINOTHINI 24 F + + + + - - + + - - - 2+ L 28 49 A + + - 
 
 68
Sl
. N
o.
 
N
am
e 
A
ge
 
Se
x 
N
ec
k 
  
R
ig
id
ity
 
Fe
ve
r 
K
er
ni
ng
 
B
ru
dz
in
sk
i 
C
ra
ni
al
 N
 
C
VA
 
A
lte
re
d 
Se
ns
or
iu
m
H
ea
da
ch
e 
Vo
m
iti
ng
  
Se
iz
ur
es
 
Pa
pi
lle
de
m
a 
S-
C
R
P 
C
SF
 C
el
l 
C
SF
-g
lu
co
se
 
C
SF
-P
ro
te
in
 
Pr
og
no
si
s 
C
ul
tu
re
 
A
FB
 
G
ra
m
's
 S
ta
in
 
 
26 INDRA 39 F + + + + - - + + - - - 1+ L 30 49 A - - -  
27 BHUVANESWARI 33 F + + - - - - + - - + - 3+ PMN 24 58 A + - +  
28 KAMALA 39 F + + + + + - + + + + - - L 36 44 A - - -  
29 RANGITHAM 37 F + + + + + - + - - - - - L 38 44 A - - -  
30 SHENBAGA VALLI 37 F + + + - - - - - - - + 4+ PMN 21 60 A + - -  
31 SELVAM 45 M + + + + - - + - + + + 4+ PMN 23 54 A + - +  
32 RADHAKRISHNAN 53 M + + + + - - + + - - - 2+ L 31 49 A + - -  
33 KUTTIAPPAN 55 M + + + + - + - + + + - - L 38 45 D - - -  
34 SENTHILMURUGAN 43 M + + - - - - + + + + - 1+ L 30 51 A - - -  
35 ARASAPPAN 49 M + + + + - - + - - - - 1+ L 32 50 A - - -  
36 VISWANATHAN 45 M + + + + - - + + + + + 4+ PMN 18 56 A + - +  
37 DURAISELVAN 41 M + + + + - - + + + + - - L 35 40 A - - -  
38 KANNAPPAN 57 M + + - - - - - - + - - 4+ PMN 20 58 A + - -  
39 MANNANGATTI 52 M + + - - - - - + + - - - L 35 42 A - - -  
40 SAMYKANNU 48 M + + + + + - + + + + - 1+ L 30 50 A - - -  
41 SENBAGAVALLI 47 F + + - - - - + - - - - 1+ L 28 55 A - - -  
42 BEEBI JOHN 53 F + + + - + + + + + - - 1+ L 28 58 A - - -  
43 MARIYAMMAL 56 F + + + + - + - - - - - - L 38 45 A - - -  
44 AMSAVALLI 44 F + + - - - - + + + - - 2+ L 29 50 A + - -  
45 JAYALAKSHMI 54 F + + + + - - - - - + - - L 36 40 D - - -  
46 LAKSHMI 41 F + + + + - - + + + - - 3+ PMN 20 58 A + - -  
47 NADESAN 66 M + + + - - - + + - - - - L 36 41 A - - -  
48 RAMASAMY 63 M + + - - - - + + + + + 3+ PMN 18 62 A + - -  
49 JOTHI 63 F + + + - - - - - - - - 3+ PMN 22 59 D + - -  
50 ARIYAMMAL 75 F + + + - + - + + + + - - L 39 43 D - - -  
